Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-17 Sale |
2025-03-18 6:45 pm |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER |
4,315 | $0.65 | $2,805 | 426,458 (Direct) |
View |
| 2024-08-26 Sale |
2024-08-28 4:15 pm |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER |
35,713 | $2.6066 | $93,091 | 105,773 (Direct) |
View |
| 2024-07-22 Sale |
2024-07-23 6:10 pm |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER |
21,740 | $7.0597 | $153,477 | 141,486 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 4:32 pm |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
33,699 | $2.9437 | $99,200 | 123,226 (Direct) |
View |
| 2023-07-24 Sale |
2023-07-25 4:25 pm |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
33,789 | $4.83 | $163,201 | 81,925 (Direct) |
View |
| 2022-07-11 Purchase |
2022-07-11 5:24 pm |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
7,500 | $3.4 | $25,500 | 15,714 (Direct) |
View |
| 2022-07-05 Purchase |
2022-07-05 4:13 pm |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
5,714 | $2.1 | $11,999 | 8,214 (Direct) |
View |
| 2021-06-04 Purchase |
2021-06-07 08:42 am |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
2,500 | $9.79 | $24,475 | 2,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Option Award |
2025-03-18 6:45 pm |
N/A 2035-03-14 |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER |
250,000 | $0 | 426,458 (Direct) |
View |
| 2023-08-24 Option Award(A) |
2025-02-06 4:15 pm |
N/A N/A |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER |
150,000 | $0 | 231,925 (Direct) |
View |
| 2024-10-09 Option Award |
2024-10-11 4:15 pm |
N/A 2034-10-09 |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-19 4:31 pm |
N/A 2034-03-15 |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER |
120,000 | $0 | 243,226 (Direct) |
View |
| 2023-08-24 Option Award |
2023-08-28 4:39 pm |
N/A N/A |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
75,000 | $0 | 156,925 (Direct) |
View |
| 2023-07-21 Option Award |
2023-07-25 4:25 pm |
N/A N/A |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
100,000 | $0 | 81,925 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:25 pm |
N/A 2033-02-28 |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-25 4:37 pm |
N/A 2032-02-23 |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 5:01 pm |
N/A 2031-02-28 |
Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer |
65,000 | $0 | 65,000 (Direct) |
View |